Skip to main content

Generics

  • DAW Rxs drive up healthcare costs, study finds

    WOONSOCKET, R.I. — "Dispense-as-written" prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system billions of dollars, according to a new study by researchers at Harvard University, Brigham and Women's Hospital, and CVS Caremark.

  • Hi-Tech Pharmacal launches topical pain treatment

    AMITYVILLE, N.Y. — The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

    The agency approved Hi-Tech’s sterile lidocaine jelly in the 2% strength, used for treating pain in procedures involving the urethra, painful urethritis and in endotracheal intubation.

    Various versions of the drug had sales of $17 million in 2010, according to IMS Health.

  • Sandoz gets OK for authorized generic of Famvir

    PRINCETON — Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

    Sandoz announced the launch of famciclovir tablets, an authorized generic of Famvir, used to treat genital herpes and cold sores in patients with healthy immune systems, and to treat shingles and herpes simplex infections of the skin and mucosa in patients with HIV.

    Authorized generics are branded drugs sold under their generic chemical names at a reduced price, often through third-party companies.

  • Actavis' generic Valtrex OKed by FDA

    MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

    The FDA approved Actavis’ valacyclovir hydrochloride tablets in the 500-mg and 1-g strengths.

    The drug is a generic version of GlaxoSmithKline’s Valtrex. Branded and generic forms of the drug had sales of about $1.5 billion in 2010, according to IMS Health.

  • Qualitest's toresmide tablets approved by FDA

    HUNTSVILLE, Ala. — The Food and Drug Administration has approved a generic drug for cardiovascular disease made by Qualitest Pharmaceuticals.

    Qualitest announced Thursday the approval of toresmide tablets in the 5-mg, 10-mg, 20-mg and 100-mg strengths.

    The drug is used to treat edema associated with congestive heart failure, kidney disease or hepatic disease, and also for hypertension.

  • Camber appoints new president

    PISCATAWAY, N.J. — The U.S. subsidiary of India-based generic drug maker Hetero Drugs has appointed Konstantin Ostaficiuk as its president, Camber said.

    Ostaficiuk, who often goes by the nickname of Kon, succeeds Briggs Arrington, who has gone on to work for Hetero’s senior management team to find new opportunities for the company’s U.S. manufacturing operations. Ostaficiuk has worked in the generic drug industry for 25 years, having joined Camber in 2009 as VP sales and marketing.

  • Mylan to launch educational site about generic drugs

    PITTSBURGH — Though more than 7-in-10 drugs dispensed in the United States today are generics, and the Food and Drug Administration holds generics to the same standards as branded drugs, misgivings among the general public still exist, fed by the occasional media report of patients experiencing bad side effects after taking certain generic drugs.

  • Watson introduces generic Famvir

    MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

    Watson Labs launched famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir and is used to treat cold sores and genital herpes in patients with and without HIV.

    Famvir and generic versions had sales of about $197 million in 2010, according to IMS Health.

X
This ad will auto-close in 10 seconds